Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC)
NCT01983865 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2014-02-19
Summary
This clinical validation study is aimed at establishing a birch pollen challenge in the Fraunhofer ECC in patients allergic to birch pollen. The symptoms will be recorded on a validated symptom score as Total Nasal Symptom Score (TNSS), allowing to determine whether the challenge is dose dependent and reproducible.
Conditions
- Seasonal Allergic Rhinitis
Interventions
- OTHER
-
Exposure to birch pollen
Sponsors & Collaborators
-
Fraunhofer-Institute of Toxicology and Experimental Medicine
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2014-01-31
- Completion
- 2014-02-28
More Related Trials
-
Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis
NCT00309062 ·Status: COMPLETED ·Phase: PHASE3
-
Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis
NCT05346718 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens
NCT00263627 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions
NCT00297843 ·Status: COMPLETED
-
Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC
NCT04641130 ·Status: COMPLETED ·Phase: NA
-
Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis
NCT01275456 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerability of a Topical Microemulsion in Patients With Allergic Rhinitis Due to Sensitization to Pollen
NCT01478425 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis
NCT01731249 ·Status: COMPLETED ·Phase: PHASE3
-
Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment
NCT02143583 ·Status: COMPLETED
-
Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma
NCT05668390 ·Status: COMPLETED ·Phase: PHASE3
-
Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC
NCT02271009 ·Status: COMPLETED ·Phase: PHASE2
-
Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects
NCT06459219 ·Status: NOT_YET_RECRUITING
-
SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding
NCT01639768 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen
NCT01728519 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study
NCT03644680 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
NCT03157505 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants
NCT06037148 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit
NCT00209365 ·Status: COMPLETED ·Phase: NA
-
Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen
NCT01719133 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
NCT02166268 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever
NCT00310466 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
NCT01144429 ·Status: COMPLETED ·Phase: PHASE2
-
Study of DM-101PX in Adults With Birch Pollen Allergy
NCT07254871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Tolerability of ALK Tree Tablet
NCT00535639 ·Status: COMPLETED ·Phase: PHASE1
-
PURETHAL Birch RUSH Study
NCT01918956 ·Status: COMPLETED ·Phase: PHASE4